AstraZeneca plc Ordinary US$0.25 (AZN)
Search for shares
News, reports & tips
-
Friday broker round-up - UPDATE
03 Feb, 2012 09:55
Royal Bank of Scotland: Deutsche Bank downgrades to hold from buy. -
London close: Stocks finish up after US data
02 Feb, 2012 16:37
After a morning session in the red, UK stocks erased losses in afternoon trading after some better-than-expected data Stateside helped the outlook for the world's largest economy. Leading the rise… -
FTSE 100 movers: Miners surge on Glencore-Xstrata merger speculation
02 Feb, 2012 14:46
Meanwhile, confirmation of a merger between Swiss commodities giants Glencore and Xstrata sent the two stocks to the top of the pile today, with Xstrata jumping 10% and Glencore rising… -
London midday: Footsie flat despite mining strength, Xstrata surges
02 Feb, 2012 12:03
Xstrata/Glencore surge on merger talks.Mining strength outweighed by Astra, Unilever, Shell.China considering increasing involvement in Eurozone rescue. -
Broker tips: AstraZeneca, Kazakhmys, Imperial Tobacco
02 Feb, 2012 11:16
Panmure Gordon has reiterated its buy recommendation for drugs giant AstraZeneca after the group's fourth quarter results came broadly in line with forecasts. -
Broker snap: Panmure remains a buyer of AstraZeneca
02 Feb, 2012 10:15
Panmure Gordon has reiterated its buy recommendation for drugs giant AstraZeneca after the group's fourth quarter results came broadly in line with forecasts. -
Thursday broker round-up
02 Feb, 2012 09:15
AstraZeneca: Panmure Gordon maintains buy rating and 3,600p target. -
London open: Stocks pull back but Xstrata soars
02 Feb, 2012 08:35
Stocks opened slightly lower on Thursday, pulling back from the +100 point gain for the Footsie yesterday as markets celebrated positive global macroeconomic data with manufacturing indices in the UK,… -
AstraZeneca to cut 7,300 jobs, predicts lower earnings in 2012 - UPDATE
02 Feb, 2012 08:04
Pharmaceuticals giant AstraZeneca has reported a strong rise in earnings in 2011 but, in an attempt to "enhance productivity" and reduce costs, the company has revealed it will by making… -
Wednesday broker round-up - UPDATE
01 Feb, 2012 10:00
Shire Pharmaceuticals: Credit Suisse maintains outperform rating and 2,350p target. -
London close: Euro worries drag Footsie down 1.1%
30 Jan, 2012 17:13
Just nine stocks in the FTSE 100 finished above water on Monday as the Eurozone crisis weighed heavily on sentiment. With the borrowing rate of Portuguese debt surging, Greek talks… -
Miners sold off as dollar gains on euro crisis
30 Jan, 2012 14:50
The Eurozone crisis sparked a sell-off in the industrial metals and mining sector today, as ongoing talks in Greece and this afternoon's EU summit weighed on market sentiment.
This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2012. All rights reserved.
Prices delayed by at least 15 minutes.
Regulatory announcements
-
Transaction in Own Shares
09 Feb, 2012 07:00
AstraZeneca -
Transaction in Own Shares
08 Feb, 2012 07:00
AstraZeneca -
Transaction in Own Shares
07 Feb, 2012 07:00
AstraZeneca -
Transaction in Own Shares
06 Feb, 2012 07:00
AstraZeneca -
Holding(s) in Company
03 Feb, 2012 16:30
AstraZeneca -
Director/PDMR Shareholding
03 Feb, 2012 15:30
AstraZeneca -
Transaction in Own Shares
03 Feb, 2012 07:00
AstraZeneca -
Share Repurchase Programme
02 Feb, 2012 13:00
AstraZeneca -
Transaction in Own Shares
02 Feb, 2012 07:05
AstraZeneca -
Final Results - Part 3 of 3
02 Feb, 2012 07:01
AstraZeneca -
Final Results - Part 2 of 3
02 Feb, 2012 07:00
AstraZeneca -
Final Results - Part 1 of 3
02 Feb, 2012 07:00
AstraZeneca